Science Explorer Back to mapMap
Discussion
Researcher · Klinikum Mutterhaus der Borromäerinnen · Germany

Michael Clemens

Michael Clemens publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.

OpenAlex
World rank
#434,213
of 7,710,434 ranked researchers
Rank in Germany
#21,392
of 364,343
Works
188
Citations
12k
Citations per work
65.3
h-index
45
i10-index 85Top 4.8% in Oncology
Michael Clemens

What does Michael Clemens research?

Michael Clemens's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (18%).

Health Sciences: 93 works · 49.4% of their workMedicine: 93 works · 49.4% of their workOncology: 48 works · 25.7% of their workPulmonary and Respiratory Medicine: 25 works · 13.2% of their workSurgery: 10 works · 5.4% of their workPathology and Forensic Medicine: 10 works · 5.1% of their workEverything else: 61 works · 32.7% of their workLife Sciences: 34 works · 17.9% of their workBiochemistry, Genetics and Molecular Biology: 34 works · 17.9% of their workCancer Research: 24 works · 12.5% of their workMolecular Biology: 10 works · 5.4% of their workTHEIR WORKMichael Clemens188works
Life Sciences18%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine9349.4%
  2. Everything else6132.7%
    1. Biochemistry, Genetics and Molecular Biology3417.9%
  1. 1Oncology26% of their works
  2. 2Pulmonary and Respiratory Medicine13% of their works
  3. 3Cancer Research12% of their works
  4. 4Molecular Biology5% of their works
  5. 5Surgery5% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Michael Clemens's research?

The keywords of their largest research topics: Chemotherapy, Molecular Subtypes, Neoadjuvant Therapy, Breast Cancer, Metastatic Breast Cancer, Breast Tumours, Gene Expression and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Chemotherapy703 topics
  2. Molecular Subtypes652 topics
  3. Neoadjuvant Therapy642 topics
  4. Breast Cancer542 topics
  5. Metastatic Breast Cancer542 topics
  6. Breast Tumours451 topic
  7. Gene Expression451 topic
  8. Targeted Therapy322 topics
  9. Chemotherapy-Induced Peripheral Neuropathy311 topic
  10. HER2311 topic
  11. Taxanes311 topic
  12. Trastuzumab311 topic
  13. CDK4/6 Inhibitors231 topic
  14. Palbociclib231 topic
  15. Cetuximab201 topic
  16. KRAS Mutations201 topic
  17. Pancreatic Cancer191 topic
  18. Surgical Complications191 topic
  19. ALK Inhibitors181 topic
  20. EGFR Mutations181 topic
  21. Cancer Genomics141 topic
  22. Mutational Signatures141 topic

Where does Michael Clemens work?

Michael Clemens's main affiliation in the publication record is Klinikum Mutterhaus der Borromäerinnen, Germany.

How many publications and citations does Michael Clemens have?

OpenAlex counts 188 works and 12,271 citations for Michael Clemens, an h-index of 45, ranking #434,213 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Michael Clemens

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Clemens. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.